Recursion Pharmaceuticals, Inc. (RXRX) market cap

Market cap today
$1.70B

Recursion Pharmaceuticals, Inc. (RXRX) has a market cap of $1.70B. At the end of fiscal 2025 (December 31, 2025) its market cap was $1.83B. That is 1.3% lower than the $1.85B of fiscal 2024. Today's figure is 7.3% below the fiscal 2025 year-end. Figures as of 18 Nov 2026, 11:36 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$1.70B
Market cap, fiscal 2025
$1.83B
Change on fiscal 2024
−1.3%
Highest on record
$2.15Bfiscal 2021
Lowest on record
$1.35Bfiscal 2022
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Recursion Pharmaceuticals, Inc. market cap, in more detail

Across the 5 fiscal year-ends on record (2021–2025), the highest was $2.15B in fiscal 2021 and the lowest $1.35B in fiscal 2022.

History · 5 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Recursion Pharmaceuticals, Inc. market cap, year by year

Recursion Pharmaceuticals, Inc. (RXRX) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$1.70B—$2.72—
2025$1.83B 1.3% down$4.09447.45M
2024$1.85B 9.6% down$6.76274.21M
2023$2.05B 51.4% up$9.86207.85M
2022$1.35B 37.0% down$7.71175.54M
2021$2.15B—$17.13125.35M
2020———21.78M
2019———21.57M

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

More on RXRX

Recursion Pharmaceuticals, Inc., figure by figure

Recursion Pharmaceuticals, Inc. (RXRX) overview: price, valuation and scorecard

Recursion Pharmaceuticals, Inc. market cap: questions and answers

What is Recursion Pharmaceuticals, Inc.'s market cap?

Recursion Pharmaceuticals, Inc. (RXRX) has a market cap of $1.70B. At the end of fiscal 2025 (December 31, 2025) its market cap was $1.83B. That is 1.3% lower than the $1.85B of fiscal 2024.

What are the highest and lowest market cap figures on record for Recursion Pharmaceuticals, Inc.?

Across the 5 fiscal year-ends on record (2021–2025), the highest was $2.15B in fiscal 2021 and the lowest $1.35B in fiscal 2022.

How is Recursion Pharmaceuticals, Inc.'s market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For Recursion Pharmaceuticals, Inc. it is on record here for 5 fiscal years, 2021 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Recursion Pharmaceuticals, Inc. (RXRX) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/RXRX/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.